Genetic and clinical mosaicism in a type of epidermal nevus.

BACKGROUND Many skin disorders are characterized by a mosaic pattern, often with alternating stripes of affected and unaffected skin that follow the lines of Blaschko. These nonrandom patterns may be caused by a postzygotic mutation during embryogenesis. We studied the genetic basis of one such disorder, epidermal nevus of the epidermolytic hyperkeratotic type. Epidermolytic hyperkeratosis is an autosomal dominant blistering skin disease arising from mutations in the genes for keratin (K) 1 and 10. The offspring of patients with epidermal nevi may have generalized epidermolytic hyperkeratosis. METHODS We studied the K1 and K10 genes in blood and in the keratinocytes and fibroblasts of lesional and nonlesional skin from three patients with epidermal nevi and four of their offspring with epidermolytic hyperkeratosis. RESULTS In the patients with epidermal nevi, point mutations in 50 percent of the K10 alleles of epidermal cells were found in keratinocytes from lesional skin; no mutations were detected in normal skin. This mutation was absent or underrepresented in blood and skin fibroblasts. In the offspring with epidermolytic hyperkeratosis, the same mutations as those in the parents were found in 50 percent of the K10 alleles from all cell types examined. CONCLUSIONS Epidermal nevus of the epidermolytic hyperkeratotic type is a mosaic genetic disorder of suprabasal keratin. The correlation of mutations in the K10 gene with lesional skin and the correlation of the normal gene with normal skin provide evidence that genetic mosaicism can cause clinical mosaicism.

[1]  E. Fuchs,et al.  Intermediate filaments and disease: mutations that cripple cell strength , 1994, The Journal of cell biology.

[2]  E. Fuchs,et al.  Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. , 1994, The Journal of clinical investigation.

[3]  S. Bale,et al.  Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. , 1994, American journal of human genetics.

[4]  H. Kerl,et al.  Melanotic macules following Blaschko's lines in McCune‐Albright syndrome , 1994, The British journal of dermatology.

[5]  S. Bale,et al.  Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. , 1994, The Journal of investigative dermatology.

[6]  D. Roop,et al.  Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing. , 1994, The Journal of investigative dermatology.

[7]  E. Lane,et al.  Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). , 1994, The Journal of investigative dermatology.

[8]  D. Hohl,et al.  A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis. , 1993, Human molecular genetics.

[9]  A. Letai,et al.  Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Elaine Fuchs,et al.  The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes , 1992, Cell.

[11]  S. Bale,et al.  A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis , 1992, Cell.

[12]  D Hohl,et al.  Mutations in the Rod Domains of Keratins 1 and 10 in Epidermolytic Hyperkeratosis , 1992, Science.

[13]  E. Fuchs,et al.  Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Amos,et al.  Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q , 1992, Nature Genetics.

[15]  E. Fuchs,et al.  Of mice and men: Genetic skin diseases of keratin , 1992, Cell.

[16]  C. Francomano,et al.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Lane,et al.  A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering , 1992, Nature.

[18]  Alana L. Rothman,et al.  Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. , 1991, Science.

[19]  Elaine Fuchs,et al.  Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses , 1991, Cell.

[20]  E. Fuchs,et al.  Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease , 1991, Cell.

[21]  E. Fuchs,et al.  Deletions in epidermal keratins leading to alterations in filament organization in vivo and in intermediate filament assembly in vitro , 1990, The Journal of cell biology.

[22]  E. Gershon,et al.  Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Caputo,et al.  Epidermolytic hyperkeratosis: generalized form in children from parents with systematized linear form , 1990, The British journal of dermatology.

[24]  E. Kawasaki.  Amplification of RNA , 1990 .

[25]  E. Fuchs,et al.  Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments , 1989, The Journal of cell biology.

[26]  E. Fuchs,et al.  Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation , 1988, The Journal of cell biology.

[27]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[28]  I. Anton‐Lamprecht.  Genetically induced abnormalities of epidermal differentiation and ultrastructure in ichthyoses and epidermolyses: pathogenesis, heterogeneity, fetal manifestation, and prenatal diagnosis. , 1983, The Journal of investigative dermatology.

[29]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[31]  L. P. Barker,et al.  Bullous congenital ichthyosiform erythroderma. , 1953, A.M.A. archives of dermatology and syphilology.